Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-13-052427
Filing Date
2013-02-13
Accepted
2013-02-12 19:37:59
Documents
2
Group Members
BOXER ASSET MANAGEMENT INC.IVAN LIEBERBURGJOSEPH LEWISMVA INVESTORS, LLCNEIL REISMAN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13G d483134dsc13ga.htm SC 13G/A 98438
2 EX-1 d483134dex991.htm EX-99.1 5233
  Complete submission text file 0001193125-13-052427.txt   105412
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45969 | Film No.: 13599089
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 440 STEVENS AVENUE SUITE 100 SOLANA BEACH CA 92075
Business Address 440 STEVENS AVENUE SUITE 100 SOLANA BEACH CA 92075 (858) 400-3112
Boxer Capital, LLC (Filed by) CIK: 0001465837 (see all company filings)

EIN.: 203828456 | State of Incorp.: DE
Type: SC 13G/A